期刊文献+

血浆催乳素水平与绝经前乳腺癌危险性的关系评估 被引量:2

Relationship between plasma prolactin concentration and risk of breast cancer among premenopausal women
下载PDF
导出
摘要 目的:评估血浆催乳素(PRL)水平与绝经前女性乳腺癌危险性的关系。方法:采用放射免疫法测定65例绝经前女性乳腺癌患者(病例组)和65例匹配对照者(对照组)的血浆PRL水平,条件logistic回归分析血浆PRL水平与绝经前乳腺癌危险性的关系。根据肿瘤的临床病理特征对病例组再进行分组,评价血浆PRL水平与乳腺癌各亚组危险性的关系。结果:病例组血浆PRL水平显著高于对照组(P〈0.01)。血浆PRL水平上四分位数相比下四分位数的调整OR(95%CI)为1.54(0.84-4.07),趋势P=0.031;PRL与绝经前乳腺癌危险性的关系在雌激素受体阳性的肿瘤中稍增强,但不随肿瘤大小、病理类型、肿瘤分级、淋巴结转移情况而变化。结论:血浆PRL水平与绝经前女性乳腺癌的危险性呈正相关,尤其是雌激素受体阳性的乳腺癌患者。 Objective: To estimate the association of plasma prolactin( PRL) concentration with the risks of breast cancer among premenopausal women. Methods: The concentration of plasma PRL was measured in 65 premenopausal women with breast cancer and65 matched control subjects by radioimmunoassay. The relations between the plasma PRL concentration and the breast cancer in premenopausal women were observed using conditional logistic regression analysis. All the cases were grouped according to the pathological features; the association of the level of PRL and the risk of breast cancer for different sub-groups were evaluated. Results:The plasma PRL concentration of the case group was significantly higher than that of the control group. Increased risk of breast cancer was positively related with the elevated plasma concentration of PRL( adjusted odds ratio [OR]for the highest versus the lowest quartile= 1. 54,95% confidence interval [95% CI]= 0. 84- 4. 07,Ptrend = 0. 031). The concentration of plasma PRL increased modestly in estrogen receptor positive carcinomas but did not change with the tumor size,grade or lymph node status. Conclusions: The results suggest that high plasma concentration of PRL is positively related with the breast cancer,especially estrogen receptor positive carcinomas among premenopausal women.
出处 《蚌埠医学院学报》 CAS 2015年第1期64-66,共3页 Journal of Bengbu Medical College
关键词 乳腺肿瘤 危险因素 催乳素 绝经前 breast neoplasms risk factor prolactin premenopausal
  • 相关文献

参考文献13

  • 1Clevenger CV,Furth PA,Hankinson SE,et al.The role of prolactin in mammary carcinoma[J].Endocr Rev,2003,24(1):1-27.
  • 2Tworoger SS,Hankinson SE.Prolactin and breast cancer risk[J].Cancer Lett,2006,243(2):160-169.
  • 3Tworoger SS,Sluss P,Hankinson SE.Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women[J].Cancer Res,2006,66(4):2476-2482.
  • 4Tworoger SS,Eliassen AH,Sluss P,et al.A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer[J].J Clin Oncol,2007,25(12):1482-1488.
  • 5Tworoger SS,Eliassen AH,Zhang XH,et al.A 20-Year Prospective Study of Plasma Prolactin as a Risk Marker of Breast Cancer Development[J].Cancer Res,2013,73(5):4810-4819.
  • 6Tikk K,Sookthai D,Johnson T,et al.Circulating prolactin and breast cancer risk among pre-and postmenopausal women in the EPIC cohort[J].Ann Oncol,2014,25(7):1422-1428.
  • 7Bhatavdekar JM,Patel DD,Shah NG,et al.Prolactin as a local growth promoter in patients with breast cancer:GCRI experience[J].Eur J Surg Oncol,2000,26(6):540-547.
  • 8Llovera M,Touraine P,Kelly PA,et al.Involvement of prolactin in breast cancer:redefining the molecular targets[J].Exp Gerontol,2000,35(1):41-51.
  • 9李志杰,杜昌国.乳腺良恶性疾病患者血清催乳素、雌二醇水平的比较及其临床意义[J].蚌埠医学院学报,2013,38(8):1005-1006. 被引量:4
  • 10Rose-Hellekant TA,Arendt LM,Schroeder MD,et al.Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice[J].Oncogene,2003,22(30):4664-4674.

二级参考文献6

  • 1Ferro P, Franceschini MC, Bacigalupo B, et al. Detection of circu- lating tumour cells in breast cancer patients using human mamma- globin RT-PCT: association with clinical prognostic factors [ J ]. Anticancer Res,2010,30(6) :2377 -2382.
  • 2Chen Y, Zou TN, Wu ZP, et al. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen positive circulating tumor cells by threemarker reverse transcription RT-PCR assay and its relation to clinical outcome in early breast cancer[J]. Int J Bio Markers,2010,25 (2) :59 -68.
  • 3Roncella S, Ferro P, Franceschini MC, et al. Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin [ J ]. Diagn Mol Pathol, 2010,19(2) :92 -98.
  • 4Raica M, Cimpean AM, Meche A, et al. Analysis of the immuno- histochemical expression of mammaglobin A in primary breastearcinoma and lymph node metastasis [ J ]. Rom J Morphol Embryol.2009,50(3 ) :341 - 347.
  • 5黄雄,马桢,谢文彪.原发性乳腺癌组织中人乳腺珠蛋白的表达及意义[J].肿瘤防治研究,2010,37(6):667-670. 被引量:6
  • 6进淑娟,黄焰,刘广贤,孙雪冬,谭燕,霍芳,马宏宾.人乳腺珠蛋白mRNA在腋窝淋巴结及外周血中的表达规律及其临床意义[J].军事医学科学院院刊,2010,34(5):440-443. 被引量:7

共引文献3

同被引文献14

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部